Hanna Vasarainen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hanna Vasarainen has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Antti Rannikko
Department of Urology Helsinki University Hospital Helsinki Finland
6 shared publications - Tuomas Mirtti
Research Program in Systems Oncology, Faculty of Medicine University of Helsinki Helsinki Finland
4 shared publications - Utku Lokman
Department of Urology, Isle of Wight NHS Trust-St Mary’s Hospital, Newport, United Kingdom
4 shared publications - Andrew Erickson
Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland
3 shared publications - Inari Kalalahti
Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
2 shared publications Andrew Erickson
Helsinki, Finland
1 shared publication
Latest Publications
- Open Access
- 10 December 2025
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 60, 213-217
Erectile and urinary function in patients on active surveillance for prostate cancer: results from the Finnish arm of the PRIAS trial
Objective: To evaluate longitudinal changes in urinary function (UF) and erectile function (EF) in a prospective active surveillance (AS) cohort of men with low-risk prostate cancer (PC), and to correlate urinary and sexual satisfaction with quality of life (QoL). Material and methods: The final cohort consisted of 359 men from the Finnish arm of the Prostate Cancer Research International: Active Surveillance (PRIAS) trial. Erectile function was assessed using the International Index of Erectile Function (IIEF-15) questionnaire and UF using the International Prostate Symptom Score (IPSS) questionnaire at baseline and at 1, 3, 5, 7, 9, 11, 13, and 15 years. Correlation analyses were performed between EF, UF, and QoL. Factors influencing EF and UF, including age, prostate-specific antigen (PSA), prostate volume, and number of biopsies, were analysed. Results: In all, 255 (71%) men completed the IIEF-15 and 262 (73%) the IPSS questionnaires at baseline and at least once during follow-up. The median IIEF-15 score at baseline was 56 (interquartile range [IQR] 28–65), decreasing to 42 (IQR 12–62) after 5 years. Median IPSS scores increased from 7 (4–13 IQR) at baseline to 10 (5.5–14.5 IQR) at 3 years. Overall sexual satisfaction and IPSS QoL remained stable throughout follow-up. Conclusion: AS did not cause short-term disturbances in EF or UF, as measured by standardised IIEF-15 and IPSS questionnaires. Although EF and UF significantly declined over the longest follow-up reported in the literature, overall sexual satisfaction and urinary QoL remained unaffected, suggesting that functional deterioration did not substantially impact patient-perceived QoL during AS.
- 10 December 2025
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 60, 213-217
Open AccessErectile and urinary function in patients on active surveillance for prostate cancer: results from the Finnish arm of the PRIAS trial
Objective: To evaluate longitudinal changes in urinary function (UF) and erectile function (EF) in a prospective active surveillance (AS) cohort of men with low-risk prostate cancer (PC), and to correlate urinary and sexual satisfaction with quality of life (QoL). Material and methods: The final cohort consisted of 359 men from the Finnish arm of the Prostate Cancer Research International: Active Surveillance (PRIAS) trial. Erectile function was assessed using the International Index of Erectile Function (IIEF-15) questionnaire and UF using the International Prostate Symptom Score (IPSS) questionnaire at baseline and at 1, 3, 5, 7, 9, 11, 13, and 15 years. Correlation analyses were performed between EF, UF, and QoL. Factors influencing EF and UF, including age, prostate-specific antigen (PSA), prostate volume, and number of biopsies, were analysed. Results: In all, 255 (71%) men completed the IIEF-15 and 262 (73%) the IPSS questionnaires at baseline and at least once during follow-up. The median IIEF-15 score at baseline was 56 (interquartile range [IQR] 28–65), decreasing to 42 (IQR 12–62) after 5 years. Median IPSS scores increased from 7 (4–13 IQR) at baseline to 10 (5.5–14.5 IQR) at 3 years. Overall sexual satisfaction and IPSS QoL remained stable throughout follow-up. Conclusion: AS did not cause short-term disturbances in EF or UF, as measured by standardised IIEF-15 and IPSS questionnaires. Although EF and UF significantly declined over the longest follow-up reported in the literature, overall sexual satisfaction and urinary QoL remained unaffected, suggesting that functional deterioration did not substantially impact patient-perceived QoL during AS.
- 21 December 2021
- Published by Wiley in European Journal of Cancer Care
- Vol. 31 (1) , e13548
Men's experiences of the impact of penile cancer surgery on their lives: A qualitative study
Objective Surgery is the primary treatment for invasive penile cancer (PC). Postoperative changes in genital anatomy and function may lead to altered body and self-image, compromised sexual function and subsequent psychological problems. The aim of this study is to describe men's experiences of the impact of PC surgical treatment on their lives. Methods The institutional databases of two Finnish university hospitals were searched for patients who underwent surgery for invasive PC between 2009 and 2019. Of 107 men, 29 agreed to an interview or a response letter. The data were analysed by thematic analysis. Results The men experienced that their self-image had changed after PC diagnosis and treatment to a ‘cancer-modified me’. They also experienced that physical symptoms after surgery defined their everyday, as well as sexual, lives and that the whole content of life changed. Conclusion Support and counselling for physical, mental, sexual and social factors should be part of the treatment of men with PC.
- 21 December 2021
- Published by Wiley in European Journal of Cancer Care
- Vol. 31 (1) , e13548
Men's experiences of the impact of penile cancer surgery on their lives: A qualitative study
Objective Surgery is the primary treatment for invasive penile cancer (PC). Postoperative changes in genital anatomy and function may lead to altered body and self-image, compromised sexual function and subsequent psychological problems. The aim of this study is to describe men's experiences of the impact of PC surgical treatment on their lives. Methods The institutional databases of two Finnish university hospitals were searched for patients who underwent surgery for invasive PC between 2009 and 2019. Of 107 men, 29 agreed to an interview or a response letter. The data were analysed by thematic analysis. Results The men experienced that their self-image had changed after PC diagnosis and treatment to a ‘cancer-modified me’. They also experienced that physical symptoms after surgery defined their everyday, as well as sexual, lives and that the whole content of life changed. Conclusion Support and counselling for physical, mental, sexual and social factors should be part of the treatment of men with PC.
- Open Access
- 1 December 2018
- Published by Elsevier in European Urology Focus
- Vol. 4 (6) , 867-873
PTEN Loss but Not ERG Expression in Diagnostic Biopsies Is Associated with Increased Risk of Progression and Adverse Surgical Findings in Men with Prostate Cancer on Active Surveillance
- 1 December 2018
- Published by Elsevier in European Urology Focus
- Vol. 4 (6) , 867-873
Open AccessPTEN Loss but Not ERG Expression in Diagnostic Biopsies Is Associated with Increased Risk of Progression and Adverse Surgical Findings in Men with Prostate Cancer on Active Surveillance
- 30 September 2017
- Published by Springer Nature
- p. 83-94
Triggers for Intervention
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e1380-e1382
PTEN status in diagnostic biopsies predicts active surveillance rebiopsy Gleason upgrade, treatment change and adverse surgical histopathological findings
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e1380-e1382
PTEN status in diagnostic biopsies predicts active surveillance rebiopsy Gleason upgrade, treatment change and adverse surgical histopathological findings
- 1 March 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (3) , e957-e957a
957 A single center comparison between protocol based (PRIAS) and non-protocol based (ERSPC) prostate cancer active surveillance cohorts
- 1 March 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (3) , e957-e957a
957 A single center comparison between protocol based (PRIAS) and non-protocol based (ERSPC) prostate cancer active surveillance cohorts